The authors compare the detection of metastases in sentinel lymph nodes (SLNs) and nonsentinel lymph nodes (NSLNs) using hematoxylin-eosin (HE) staining versus immunohistochemistry (IHC). Thirty-six patients with breast carcinoma undergo exeresis of the primary tumor and of 50 SLNs and 491 NSLNs. Sentinel lymph nodes are sectioned into transverse slices of 2- to 3-mm thickness, and a cytologic smear and a frozen section were obtained from each slice. The slices are completely cut into serial sections at 100-µm intervals. Two consecutive 4-µm-thick sections are then obtained from each level and were prepared for HE staining and IHC. Nonsentinel lymph nodes are evaluated similarly to SLNs. The authors obtain 4076 SLN sections and 32 012 NSLN sections, for a total of 36 088 sections. A comparison of HE staining versus IHC based on the total number of sections shows a sensitivity of 93.8%, a negative predictive value of 98.9%, and an accuracy of 99.1%. The values obtained by HE staining are similar to those obtained by IHC.
Allweis TM, Badriyyah M., Bar Ad V., et al. Current controversies in sentinel lymph node biopsy for breast cancer. Breast. 2003;12(3):163-171.
2.
Cserni G., Amendoeira I., Apostolikas N., et al. Pathological work-up of sentinel lymph nodes in breast cancer: review of current data to be considered for the formulation of guidelines . Eur J Cancer. 2003;39(12): 1654-1667.
3.
Schwartz GFClinical practice guidelines for the use of axillary sentinel lymph node biopsy in carcinoma of the breast: current update. Breast J.2004;10(2):85-88.
4.
Clayton F., Hopkins CLPathologic correlates of prognosis in lymph node—positive breast carcinomas . Cancer. 1993;71(5):1780-1790.
5.
Hortobagyi GNTreatment of breast cancer. N Engl J Med.1998;339(14):974-984.
6.
Rosen PP, Saigo PE, Braun DW, et al. Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size. Ann Surg.1981 ;194(5):585-591.
7.
Tanis PJ, Nieweg OE, Olmos Rav, et al. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg.2001;192(3):399-409.
8.
Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer . Ann Surg.1994;220(3):391-401.
9.
Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med.1998;339(14):941-946.
10.
Wells CA, Heryet J., Brochier J., et al. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer.1984;50(2):193-197.
11.
Chu KU, Turner RR, Hansen NM, et al. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol. 1999;6(8):756-761.
12.
King TA, Ganaraj A., Fey JV, et al. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy . Cancer. 2004;101(5):926-933.
13.
Moore KH, Thaler HT, Tan LK, et al. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biological metastasis or procedural artifact?Cancer. 2004;100(5): 929-934.
14.
Trojani M., de Mascarel I., Bonichon F., et al. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer.1987;55(6):303-306.
15.
Wong SL, Chao C., Edwards MJ, et al. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Am J Surg.2001;182(4):330-334.
16.
Zhang PJ, Reisner RM, Nangia R., et al. Effectiveness of multiple-level sectioning in detecting axillary nodal micrometastasis in breast cancer. Arch Pathol Lab Med.1998;122(8):687-690.
17.
Barranger E. , Antonine M., Grahek D., et al. Intraoperative imprint cytology of sentinel nodes in breast cancer. J Surg Oncol.2004;86(3):128-133.
18.
Chao C.The use of frozen section and immunohistochemistry for sentinel lymph node biopsy in breast cancer. Am Surg.2004;70(5):414-419.
19.
Cox C., Centeno B., Dickson D., et al. Accuracy of intraoperative imprint cytology for sentinel lymph node evaluation in the treatment of breast carcinoma. Cancer . 2005;105(1):13-20.
20.
Creager AJ, Geisinger KRIntraoperative evaluation of sentinel lymph nodes for breast carcinoma: current methodologies. Adv Anat Pathol. 2002;9(4):233-243.
21.
Cserni G.The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients. Am Surg.2001;67(1):86-91.
22.
Deo S., Samaiya A., Jain P., et al. Sentinel lymph node biopsy assessment using intraoperative imprint cytology in breast cancer patients: results of a validation study. AsianJ Surg.2004;27(4):294-298.
23.
Derossis AM , Fey J., Yeung H., et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg.2001;193(5):473-478.
24.
Fortunato L., Amini M., Farina M., et al. Intraoperative examination of sentinel nodes in breast cancer: is the glass half full or half empty?Ann Surg Oncol. 2004; 11(11):1005-1010.
25.
Gillanders WE , Mikhitarian K., Hebert R., et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg.2004;239(6):828-837.
26.
Holck S., Galatius H., Engel U., et al. False-negative frozen section of sentinel lymph node biopsy for breast cancer. Breast. 2004;13(1):42-48.
27.
Litz CE, Beitsch PD, Roberts CA, et al. Intraoperative cytologic diagnosis of breast sentinel lymph nodes in the routine, nonacademic setting: a highly specific test with limited sensitivity. Breast J.2004;10(5):383-387.
28.
Lockett MA, Baron PL, O'Brien PH, et al. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase—polymerase chain reaction panel. J Am Coll Surg.1998;187(1):9-16.
29.
Motomura K. , Inaji H., Komoike Y., et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery . Br J Surg.2000;87(5):597-601.
30.
Ouellette RJ , Richard D., Maicas E.RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes. Am J Clin Pathol.2004;121(5):637-643.
31.
Ravichandran D., Kocjan G., Falzon M., et al. Imprint cytology of the sentinel lymph node in the assessment of axillary node status in breast carcinoma. Eur J Surg Oncol.2004;30(3):238-242.
32.
Tabbara SOSentinel lymph node: the role of intraoperative cytology. Pathol Case Rev.2001;6(5):191-195.
33.
Wada N., Imoto S., Hasebe T., et al. Evaluation of intraoperative frozen section diagnosis of sentinel lymph nodes in breast cancer. Jpn J Clin Oncol. 2004;34(3):113-117.
34.
Weigelt B., Verduijn P., Bosma AJ, et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. Br J Cancer.2004;90(8):1531-1537.
35.
Weinberg ES , Dickson D., White L., et al. Cytokeratin staining for intraoperative evaluation of sentinel lymph nodes in patients with invasive lobular carcinoma . Am J Surg.2004;188(4):419-422.
36.
Zgajnar J., Frkovic-Grazio S., Besic N., et al. Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients: results of a large series. J Surg Oncol.2004;85(2):82-86.
37.
Hsu SM, Raine L., Fanger H.Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem.1981; 29(4): 577-580.
38.
Dowlatshahi K., Fan M., Snider HC, et al. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer. 1997;80(7):1188-1197.
39.
Huvos AG, Hutter Rvp, Berg JWSignificance of axillary macrometastases and micrometastases in mammary cancer . Ann Surg.1970;173(1):44-46.
40.
Mc Masters KM, Giuliano AE, Ross MI, et al. Sentinel-lymph-node biopsy for breast cancer: not yet the standard of care. N Engl J Med.1998;339(14):990-995.
41.
Mc Masters KM, Wong SL, Chao C., et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg.2001;234(3):292-300.
42.
Sandrucci S. , Casalegno PS, Percivale P., et al. Sentinel lymph node mapping and biopsy for breast cancer: a review of the literature relative to 4791 procedures . Tumori. 1999;85(6):425-434.
43.
Veronesi U. , Zurrida S., Mazzarol G., et al. Extensive frozen section examination of sentinel nodes to determine selective axillary dissection. World J Surg.2001;25(6):806-808.
44.
Cochran AJSurgical pathology remains pivotal in the evaluation of “sentinel” lymph nodes. Am J Surg Pathol. 1999;23(10):1169-1172.
45.
Dowlatshakhi K., Fan M., Bloom KJ, et al. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. Cancer. 1999;86(6):990-995.
46.
Cserni G.A model for determining the optimum histology of sentinel lymph nodes in breast cancer. J Clin Pathol.2004;57(5):467-471.
47.
Czerniecki BJ, Scheff AM, Callans LS, et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer. 1999;85(5):1098-1103.
48.
Freneaux P. , Nos C., Vincent-Salomon A., et al. Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice. Mod Pathol. 2002;15(6):641-646.
49.
Noguchi M.Current controversies concerning sentinel lymph node biopsy for breast cancer . Breast Cancer Res Treat. 2004;84(3):261-271.
50.
Silverberg SGSentinel node processing: recommendations for pathologists. Am J Surg Pathol. 2002;26(3):383-385.
51.
Turner RR, Ollila DW, Stern S., et al. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol. 1999; 23(3):263-267.
52.
Weaver DLMicrometastases in sentinel lymph nodes: pathologic aspects. Pathol Case Rev.2003;8(5):220-226.
53.
Yared MA, Middleton LP, Smith TL, et al. Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol. 2002;26(3):377-382.
54.
Cserni G., Amendoeira I., Apostokilas N., et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer: results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol. 2004;57(7):695-701.
55.
Viale G., Sonzogni, Pruneri G, et al. Histopathologic examination of axillary sentinel lymph nodes in breast carcinoma patients. J Surg Oncol.2004;85(3):123-128.
56.
Chiu A., Hoda SA, Yao DX, et al. A potential source of false-positive sentinel nodes: immunostain misadventure. Arch Pathol Lab Med.2001;125(11):1497-1499.
57.
Diaz NM, Vrcel V., Centeno BA, et al. Modes of benign mechanical transport of breast epithelial cells of axillary lymph nodes. Adv Anat Pathol.2005;12(1):7-9.
58.
Hoda SA, Resetkova E., Yusuf Y., et al. Megakaryocytes mimicking metastatic breast carcinoma. Arch Pathol Lab Med.2002;126(5):618-620.
Linden MD, Zarbo RJCytokeratin immunostaining patterns of benign reactive lymph nodes: applications for the evaluation of sentinel lymph node specimen. Appl Immunohistochem Molecul Morphol.2001;9(4):297-301.
61.
Cserni G., Bianchi S., Boecker W., et al. Improving the reproducibility of diagnosis micrometastases and isolated tumor cells. Cancer.2005;103(2):358-367.
62.
Diaz NM, Cox CE, Ebert M., et al. Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol. 2004;28(12):1641-1645.
63.
Hansen NM, Ye X., Grube BJ, et al. Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg.2004; 139(6):634-639.
64.
Klauber-DeMore N., Van Zee KJ, Linkov I., et al. Biological behavior of human breast cancer micrometastases. Clin Cancer Res.2001 ;7(8):2434-2439.
65.
Lilleng PK, Mæhle BO, Hartveit F.The size of a micrometastasis in the axilla in breast cancer: a study of nodal tumour-load related to prognosis. Eur J Gynaecol Oncol.1998;20(3):220-224.
66.
Mascarel I. , Bonichon F., Coindre JM, et al. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer.1992;66(3):523-527.
67.
Noguchi M.Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes . Br J Surg.2002;89(12):1505-1515.
68.
Peters-Engl C., Konstantiniuk P., Tausch C., et al. The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian Sentinel Node Biopsy Study Group. Br J Cancer.2004;91(10):1782-1786.
69.
Poindexter NJ, Sahin A., Hunt KK, et al. Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer . Breast Cancer Res.2004;6(4):408-415.
70.
Sakorafas GH , Geraghty J., Pavlakis G.The clinical significance of axillary lymph node micrometastases in breast cancer. Eur J Surg Oncol.2004;30(8):807-816.
71.
Schrenk P., Hatzl-Griesenhofer M., Shamiyeh A., et al. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol.2001;77(3):165-170.
72.
Weaver DLSentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant?Am J Surg Pathol. 2003;27(6):842-845.
